Bioxyne Ltd has released a press release.
Revenue Guidance
Filed with ASX ·
On 6ix: 6ix.com/news/revenue-guidance
6ix hasn’t read this filing yet.
Earlier from Bioxyne
- Addendum to Presentation dated 18 November 2024
- Response to ASX Price Query
- Investor Presentation November 2024
- Bioxyne Extends Contract with Aura Therapeutics
- Response to ASX Aware Query
Later from Bioxyne
- Quarterly Activities Report December 2024 Revised
- BXN H1 FY25 Results Presentation
- Pause in Trading
- Trading Halt
- Bioxyne Raises A$3 million in Capital Raise
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne